988 Results

People

  1. Lesokhin
    Lesokhin
  2. Landgren
    Landgren
  3. Hassoun
    Hassoun
  4. Mailankody
    Mailankody
  5. Landau
    Landau
  6. Giralt
    Giralt
  7. Korde
    Korde
  8. Hultcrantz
    Hultcrantz
  9. Chung
    Chung
  10. Shah
    Shah

Groups

  1. Center for Hematologic Malignancies (988)
  2. Department of Medicine (988)
  3. Hematologic Malignancies, Division of (988)
  4. Myeloma (988)
  5. Hematologic Malignancies Research (651)
  6. Survivorship Research (356)
  7. Sloan Kettering Institute Postdocs (292)
  8. Bone Marrow Transplant (289)
  9. Epidemiology and Biostatistics (209)
  10. Biostatistics Service (175)
  1. "Myeloma"
Formats
  1. Meeting Abstract (543)
  2. Journal Article (358)
  3. Review (36)
  4. Research Letter (19)
  5. Book Section (10)
  6. Guidelines (10)
  7. Correspondence (6)
  8. Editorial (5)
  9. Conference Paper (1)
Groups
  1. Center for Hematologic Malignancies (988)
  2. Department of Medicine (988)
  3. Hematologic Malignancies, Division of (988)
  4. Myeloma (988)
  5. Hematologic Malignancies Research (651)
  6. Survivorship Research (356)

More Groups

People
  1. Alexander Lesokhin (363)
  2. Carl Landgren (336)
  3. Hani Hassoun (329)
  4. Sham Mailankody (282)
  5. Malin Hultcrantz (260)
  6. Heather Landau (239)

More People

Years
  1. 2025 (13)
  2. 2024 (69)
  3. 2023 (115)
  4. 2022 (96)
  5. 2021 (76)
  6. 2020 (95)

More Years

Publications
  1. Blood (303)
  2. Clinical Lymphoma, Myeloma and Leukemia (96)
  3. Journal of Clinical Oncology (85)
  4. Haematologica (41)
  5. Biology of Blood and Marrow Transplantation (29)
  6. Blood Cancer Journal (22)

More Publications

Publishers
  1. American Society of Hematology (324)
  2. Elsevier Inc. (159)
  3. American Society of Clinical Oncology (87)
  4. Nature Publishing Group (83)
  5. Ferrata Storti Foundation (41)
  6. American Association for Cancer Research (34)

More Publishers

Results (988)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Autoimmune disease is associated with a lower risk of progression in monoclonal gammopathy of undetermined significance
    Journal Article

    Baldursdóttir, T. R.; Löve, Þ J.; Gíslason, G. K.; Björkholm, M.; Mellqvist, U. H.; Lund, S. H.; Blimark, C. H.; Turesson, I.; Hultcrantz, M.; Landgren, O.; more...
    European Journal of Haematology (2021)

    Fulltext@MSK | Save
  • Risk of infections in patients with myeloproliferative neoplasms - A population-based cohort study of 8363 patients
    Journal Article

    Landtblom, A. R.; Andersson, T. M. L.; Dickman, P. W.; Smedby, K. E.; Eloranta, S.; Batyrbekova, N.; Samuelsson, J.; Björkholm, M.; Hultcrantz, M.
    Leukemia (2021)

    Fulltext@MSK | Save
  • Routine evaluation of minimal residual disease in myeloma using next-generation sequencing clonality testing: Feasibility, challenges, and direct comparison with high-sensitivity flow cytometry
    Journal Article

    Ho, C.; Syed, M.; Roshal, M.; Petrova-Drus, K.; Moung, C.; Yao, J.; Quesada, A. E.; Benhamida, J.; Vanderbilt, C.; Liu, Y.; more...
    Journal of Molecular Diagnostics (2021)

    Fulltext@MSK | Save
  • Lifetime pesticide use and monoclonal gammopathy of undetermined significance in a prospective cohort of male farmers
    Journal Article

    Hofmann, J. N.; Beane Freeman, L. E.; Murata, K.; Andreotti, G.; Shearer, J. J.; Thoren, K.; Ramanathan, L.; Parks, C. G.; Koutros, S.; Lerro, C. C.; more...
    Environmental Health Perspectives (2021)

    Fulltext@MSK | Save
  • Designing evolutionary-based interception strategies to block the transition from precursor phases to multiple myeloma
    Review

    Maura, F.; Landgren, O.; Morgan, G. J.
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Using MALDI-TOF mass spectrometry in peripheral blood for the follow up of newly diagnosed multiple myeloma patients treated with daratumumab-based combination therapy
    Journal Article

    Eveillard, M.; Korde, N.; Ciardiello, A.; Diamond, B.; Lesokhin, A.; Mailankody, S.; Smith, E.; Hassoun, H.; Hultcrantz, M.; Shah, U.; more...
    Clinica Chimica Acta (2021)

    Fulltext@MSK | Save
  • Phase 1 study of the anti-BCMA antibody-drug conjugate AMG 224 in patients with relapsed/refractory multiple myeloma
    Research Letter

    Lee, H. C.; Raje, N. S.; Landgren, O.; Upreti, V. V.; Wang, J.; Avilion, A. A.; Hu, X.; Rasmussen, E.; Ngarmchamnanrith, G.; Fujii, H.; more...
    Leukemia (2021)

    Fulltext@MSK | Save
  • The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
    Journal Article

    Boyle, E. M.; Deshpande, S.; Tytarenko, R.; Ashby, C.; Wang, Y.; Bauer, M. A.; Johnson, S. K.; Wardell, C. P.; Thanendrarajan, S.; Zangari, M.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • A phase 1b study of once-weekly carfilzomib combined with lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma
    Journal Article

    Alsina, M.; Landgren, O.; Raje, N.; Niesvizky, R.; Bensinger, W. I.; Berdeja, J. G.; Kovacsovics, T.; Vesole, D. H.; Fang, B.; Kimball, A. S.; more...
    American Journal of Hematology (2021)

    Fulltext@MSK | Save
  • Revealing the impact of structural variants in multiple myeloma
    Journal Article

    Rustad, E. H.; Yellapantula, V. D.; Glodzik, D.; Maclachlan, K. H.; Diamond, B.; Boyle, E. M.; Ashby, C.; Blaney, P.; Gundem, G.; Hultcrantz, M.; more...
    Blood Cancer Discovery (2020)

    Fulltext@MSK | Save